Related by context. Frequent words. (Click for all words.) 65 Phase Ib II 65 CALGB 65 Phase Ib clinical 64 multicenter prospective 63 NSABP 62 phase IIa clinical 62 EORTC 62 pharmacokinetic PK 61 Clinical Trial Results 61 Randomized controlled 61 phase Ib 61 Daclizumab 60 SABCS 60 refractory chronic lymphocytic 60 randomized Phase III 60 liposomal formulation 60 ongoing Phase 1b 60 EVEREST II 59 SWOG 59 Multicenter 59 Phase IIIb 59 Gynecologic Oncology Group 59 phase IIa 59 phase IIb clinical 59 II Clinical Trial 59 relapsing multiple sclerosis 59 Patient Registry 59 PRECiSE 59 Pivotal Phase III 59 multicenter Phase 59 ACRIN 58 MORAb 58 phase IIb 58 PRECISE 58 prospective multicenter 58 sunitinib malate 58 Phase IIB 58 Phase 1b clinical 58 ThermoDox R 57 Initiate Phase 57 Phase III Clinical Trial 57 Pharmacokinetic 57 dose escalation trial 57 TASQ 57 ixabepilone 57 GRNVAC1 57 Abstract Number 57 Phase 2a clinical 57 NCCTG 57 placebo controlled Phase 57 teriflunomide 57 Arch Neurol 57 Phase 1b trial 57 SPIRIT IV 57 enzastaurin 57 RTOG 57 LCP Tacro 57 IMC #B 57 pharmacokinetics PK 57 Pivotal Trial 57 elotuzumab 56 Principle Investigator 56 Guanilib 56 Azedra 56 Phase Ia 56 Pivotal Study 56 axitinib 56 Tesetaxel 56 MERLIN TIMI 56 multicenter clinical 56 Factor VIIa 56 Co Principal Investigator 56 Gastric Cancer 56 biostatistical 56 metastatic hormone refractory 56 PEG SN# 56 xCELLigence System 56 relapsed refractory multiple myeloma 56 pertuzumab 56 Oligonucleotide 56 Clinical Trials Unit 56 proteasome inhibitor 55 placebo controlled clinical 55 Cancer Res 55 Phase 2b clinical trials 55 KRN# 55 Ixempra 55 phase 2a 55 #:#-# [031] 55 Confirmatory 55 Sym# 55 neoadjuvant 55 Chronic Heart Failure 55 J Clin Oncol 55 TG# [001] 55 Amrubicin 55 DAVANAT 55 GSK# [001] 55 ASCO Annual Meeting 55 tanespimycin 55 multicenter randomized double